Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,358 | 84,386 | 83,515 | 89,789 | 97,648 |
| Marketable Securities | 0 | 1,120 | 4,647 | 7,907 | 21,359 |
| Receivables | 20,648 | 19,910 | 19,365 | 15,268 | 12,954 |
| Other current assets | 8,488 | 7,869 | 29,839 | 30,847 | 8,311 |
| TOTAL | $96,494 | $113,285 | $137,366 | $143,811 | $140,272 |
| Non-Current Assets | |||||
| PPE Net | 56,774 | 59,231 | 61,708 | 63,621 | 70,759 |
| Intangibles | 662 | 695 | 713 | 718 | 1,511 |
| Other Non-Current Assets | 55,770 | 54,463 | 51,621 | 53,066 | 67,038 |
| TOTAL | $113,206 | $114,389 | $114,042 | $117,405 | $139,308 |
| Total Assets | $209,700 | $227,674 | $251,408 | $261,216 | $279,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,058 | 5,185 | 5,188 | 5,088 | 10,379 |
| Accounts payable and accrued liabilities | 20,476 | 19,229 | 22,324 | 21,456 | 22,353 |
| Other current liabilities | 10,099 | 9,122 | 7,105 | 13,656 | 12,007 |
| TOTAL | $43,953 | $42,047 | $60,468 | $62,995 | $53,030 |
| Non-Current Liabilities | |||||
| Long Term Debt | 43,248 | 46,157 | 19,625 | 20,531 | 14,699 |
| Deferred Revenues | 117 | 241 | 342 | 59 | 320 |
| Other Non-Current Liabilities | 46,376 | 47,845 | 53,275 | 53,492 | 69,036 |
| TOTAL | $89,624 | $89,068 | $70,450 | $72,279 | $80,937 |
| Total Liabilities | $133,578 | $131,116 | $130,918 | $135,275 | $133,967 |
| Shareholders' Equity | |||||
| Common Shares | 3,492 | 3,491 | 3,487 | 2,955 | 2,949 |
| Retained earnings | -363,191 | -346,107 | -469,294 | -439,504 | -409,921 |
| Other shareholders' equity | -37,503 | -37,050 | -21,790 | -20,632 | -26,463 |
| TOTAL | $76,123 | $96,558 | $120,489 | $125,941 | $145,612 |
| Total Liabilities And Equity | $209,701 | $227,674 | $251,407 | $261,216 | $279,579 |